Company: IMNN
Filing Date: 2025-04-04
Form Type: S-1
Source: 0001641172-25-002783
Chunk: 49

Company: Imunon, Inc.
Filing Date: 2025-04-04
Form: S-1
Chunk 49
---
 registration statement of which this prospectus is a part the information or documents listed below (except in each case the information contained in such document to the extent “furnished” and not “filed”) that we have filed with the SEC:

| ● 
 ● | Our                                                                                                                                
 Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed on February 27, 2025;                                 
 Our                                                                                                                                
 Current Reports on Form 8-K filed with the SEC on February                                                                         
 10, 2025 and  March 24, 2025,                                                                                                      
 excluding any information furnished in such reports under Item 2.02, Item 7.01 or Item 9.01); and                                  |
|:--|:-----------------------------------------------------------------------------------------------------------------------------------|
| ● | Description                                                                                                                        
 of Securities of the Company, incorporated herein by reference to Exhibit 4.7 to the Annual Report on Form 10-K of the Company for 
 the fiscal year ended December 31, 2024.                                                                                           |

In addition, all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering (excluding any information furnished rather than filed), shall be deemed to be incorporated by reference into this prospectus.

Any statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or superseded for purposes hereof to the extent that a statement contained in this prospectus or any other subsequently filed document that is deemed to be incorporated by reference into this prospectus modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.

You may request a free copy of any of the documents incorporated by reference in this prospectus (other than exhibits, unless they are specifically incorporated by reference in the documents) by writing or telephoning us at the following address:

<div align='center'>Imunon, Inc.

997 Lenox Drive, Suite 100

Lawrenceville, NJ 08648

(609) 896-9100</div>

Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus.

The documents incorporated by reference may be accessed at our website: http://www.imunon.com.

|